SFX by Ex Libris Inc.

Title:	Getting a Grip on Prions: Oligomers, Amyloids, and Pathological Membrane Interactions
Source:	Annual Review of Biochemistry [0066-4154] Caughey, Byron yr:2009

Basic

Full text

Full text available via Annual Reviews

Year:

Volume:

Issue:

Start Page:

Full text available via Annual Reviews Back Volume Collection

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Weissman, J S S. "Deadly conformations--protein misfolding in prion disease." Cell 89.4 (1997): 499-510.
description	2.	Heikenwaelder, M. "Molecular mechanisms of prion pathogenesis." Annual review of pathology 3.1 (2008): 11-40.
description	3.	Tagliavini, F. "Synthetic peptides homologous to prion protein residues 106±147 form amyloid in vitro." Proceedings of the National Academy of Sciences of the United States of America 90.20 (1993): 9673-9682.
description	4.	Kirkpatrick, P. "Eculizumab." Nature reviews. Drug discovery 6.7 (2007): 515-6.
description	5.	Fogolari, F. "Molecular dynamics simulation suggests possible interaction patterns at early steps of Î²2-microglobulin aggregation." Biophysical journal 92.5 (2006): 1673-1681.
description	6.	Soto, C. "The controversial protein-only hypothesis of prion propagation." Nature medicine 10 Suppl.Suppl. S (2004): 63-7.
description	7.	Aguzzi, A. "Mechanisms of disease - Insights into prion strains and neurotoxicity." Nature reviews. Molecular cell biology 8.7 (2007): 552-561.
description	8.	Ryou, C. "Prions and prion diseases: fundamentals and mechanistic details." Journal of microbiology and biotechnology 17.7 (2007): 1059-70.
description	9.	Collinge, J. "Prion diseases of humans and animals: their causes and molecular basis." Annual review of neuroscience 24.1: 519-550.
description	10.	Prusiner, S B B. "Prions." Proceedings of the National Academy of Sciences of the United States of America 95.23: 13363-13383.
description	11.	Aguzzi, A. "Prion biology: the quest for the test." Nature methods 4.8 (2007): 614-6.
description	12.	Ruschak, Amy M. "Fiber-dependent amyloid formation as catalysis of an existing reaction pathway." Proceedings of the National Academy of Sciences of the United States of America 104.30 (2007): 12341-12346.
description	13.	Stefani, M. "Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution." Journal of molecular medicine 81.11 (2003): 678-699.
description	14.	Novakofski, J. "Prion biology relevant to bovine spongiform encephalopathy." Journal of animal science 83.6 (2005): 1455-1476.
description	15.	Luzzatto, L. "The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria." The New England journal of medicine 355.12 (2006): 1233-43.
description	16.	Caughey, B. "BINDING OF THE PROTEASE-SENSITIVE FORM OF PRP (PRION PROTEIN) TO SULFATED GLYCOSAMINOGLYCAN AND CONGO RED (VOL 68, PG 2135, 1994)." Journal of virology 68.6 (1994): 4107-4107.
description	17.	Wolff, Shana A. "One-Step Synthesis and Characterization of Difunctionalized N-Confused Tetraphenylporphyrins." Journal of organic chemistry 69.14 (2004): 4571-4576.
description	18.	Lottin-Divoux, S. "Activation of Epstein-Barr virus/C3d receptor (gp140, CR2, CD21) on human B lymphoma cell surface triggers Cbl tyrosine phosphorylation, its association with p85 subunit, Crk-L and Syk and its dissociation with Vav." Cellular signalling 18.8 (2006): 1219-25.
description	19.	Parker, Charles J J. "Historical aspects of paroxysmal nocturnal haemoglobinuria: 'defining the disease'." British journal of haematology 117.1 (2002): 3-22.
description	20.	Takita, M. "Eculizumab in paroxysmal nocturnal hemoglobinuria." The New England journal of medicine 355.26 (2007): 2787-8.